Skip to main content
TipRanks
Go Ultimate75% OFF

Viridian Therapeutics (1S1) Cash flow

2 Followers

Viridian Therapeutics Cash Flow

DE:1S1's free cash flow for Q3 2026 was $-93.14M. For the 2026 fiscal year, DE:1S1's free cash flow was decreased by $-370.00K and operating cash flow was $-92.77M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -276.39M$ -232.32M$ -184.17M$ -93.84M$ -54.58M
$ -37.56M$ -228.65M$ -94.25M$ -115.13M$ -74.29M
$ 426.74M$ 457.74M$ 225.67M$ 322.24M$ 125.28M
$ 212.38M$ 99.59M$ 102.83M$ 155.58M$ 42.30M
$ -276.89M$ -232.83M$ -185.07M$ -94.64M$ -54.92M

Currency in USD

Viridian Therapeutics Cash Flow

-400M-200M0200M400M600M201720182019202020212022202320242025OperatingInvestingFinancing